Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)

Fixed-dose Abacavir/3TC Administered Once-daily Compared with Separate Components Twice-daily: The ALOHA Study   10/06/06

Tenofovir + Efavirenz vs Tenofovir + Efavirenz + 3TC: The COOL Trial   10/06/06

NRTI-sparing Atazanavir/Efavirenz Regimens Suppress HIV but Raise Lipids   10/03/06

Trizivir versus Unboosted Atazanavir/AZT/3TC: The ACTION Study   10/03/06









Google_______________



 

 

 

 



 

 

 

 

 


Conference
Main Page